Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth
Doleschel, Dennis, Hoff, Sabine, Koletnik, Susanne, Rix, Anne, Zopf, Dieter, Kiessling, Fabian, Lederle, Wiltrud
Published in Journal of experimental & clinical cancer research (13.09.2021)
Published in Journal of experimental & clinical cancer research (13.09.2021)
Get full text
Journal Article
Regorafenib inhibits growth, angiogenesis, and metastasis in a highly aggressive, orthotopic colon cancer model
Abou-Elkacem, Lotfi, Arns, Susanne, Brix, Gunnar, Gremse, Felix, Zopf, Dieter, Kiessling, Fabian, Lederle, Wiltrud
Published in Molecular cancer therapeutics (01.07.2013)
Published in Molecular cancer therapeutics (01.07.2013)
Get full text
Journal Article
Regorafenib (BAY 73‐4506): Antitumor and antimetastatic activities in preclinical models of colorectal cancer
Schmieder, Roberta, Hoffmann, Jens, Becker, Michael, Bhargava, Ajay, Müller, Tina, Kahmann, Nicole, Ellinghaus, Peter, Adams, Robert, Rosenthal, André, Thierauch, Karl‐Heinz, Scholz, Arne, Wilhelm, Scott M., Zopf, Dieter
Published in International journal of cancer (15.09.2014)
Published in International journal of cancer (15.09.2014)
Get full text
Journal Article
Effects of regorafenib on the mononuclear/phagocyte system and how these contribute to the inhibition of colorectal tumors in mice
Grünewald, Sylvia, Stecklum, Maria, Rizzo, Manuel, Rathjens, Jonathan, Fiebig, Lukas, Zopf, Dieter
Published in European journal of medical research (03.04.2023)
Published in European journal of medical research (03.04.2023)
Get full text
Journal Article
Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma
Shigeta, Kohei, Matsui, Aya, Kikuchi, Hiroto, Klein, Sebastian, Mamessier, Emilie, Chen, Ivy X, Aoki, Shuichi, Kitahara, Shuji, Inoue, Koetsu, Shigeta, Ayako, Hato, Tai, Ramjiawan, Rakesh R, Staiculescu, Daniel, Zopf, Dieter, Fiebig, Lukas, Hobbs, Gabriela S, Quaas, Alexander, Dima, Simona, Popescu, Irinel, Huang, Peigen, Munn, Lance L, Cobbold, Mark, Goyal, Lipika, Zhu, Andrew X, Jain, Rakesh K, Duda, Dan G
Published in Journal for immunotherapy of cancer (24.11.2020)
Published in Journal for immunotherapy of cancer (24.11.2020)
Get full text
Journal Article
Correction: Effects of regorafenib on the mononuclear/phagocyte system and how these contribute to the inhibition of colorectal tumors in mice
Grünewald, Sylvia, Stecklum, Maria, Rizzo, Manuel, Rathjens, Jonathan, Fiebig, Lukas, Zopf, Dieter
Published in European journal of medical research (24.06.2023)
Published in European journal of medical research (24.06.2023)
Get full text
Journal Article
Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma
Kissel, Maria, Berndt, Sandra, Fiebig, Lukas, Kling, Simon, Ji, Qunsheng, Gu, Qingyang, Lang, Tina, Hafner, Frank-Thorsten, Teufel, Michael, Zopf, Dieter
Published in Oncotarget (05.12.2017)
Published in Oncotarget (05.12.2017)
Get full text
Journal Article
Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models
Daudigeos-Dubus, Estelle, Le Dret, Ludivine, Lanvers-Kaminsky, Claudia, Bawa, Olivia, Opolon, Paule, Vievard, Albane, Villa, Irène, Pagès, Mélanie, Bosq, Jacques, Vassal, Gilles, Zopf, Dieter, Geoerger, Birgit
Published in PloS one (23.11.2015)
Published in PloS one (23.11.2015)
Get full text
Journal Article
Effects of chronic low‐dose aspirin treatment on tumor prevention in three mouse models of intestinal tumorigenesis
Rohwer, Nadine, Kühl, Anja A., Ostermann, Annika I., Hartung, Nicole Marie, Schebb, Nils Helge, Zopf, Dieter, McDonald, Fiona M., Weylandt, Karsten‐H.
Published in Cancer medicine (Malden, MA) (01.04.2020)
Published in Cancer medicine (Malden, MA) (01.04.2020)
Get full text
Journal Article
Pharmacologic activity and pharmacokinetics of metabolites of regorafenib in preclinical models
Zopf, Dieter, Fichtner, Iduna, Bhargava, Ajay, Steinke, Wolfram, Thierauch, Karl‐Heinz, Diefenbach, Konstanze, Wilhelm, Scott, Hafner, Frank‐Thorsten, Gerisch, Michael
Published in Cancer medicine (Malden, MA) (01.11.2016)
Published in Cancer medicine (Malden, MA) (01.11.2016)
Get full text
Journal Article
T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interaction
Pinkert, Jessica, Boehm, Hans-Henning, Trautwein, Mark, Doecke, Wolf-Dietrich, Wessel, Florian, Ge, Yingzi, Gutierrez, Eva Maria, Carretero, Rafael, Freiberg, Christoph, Gritzan, Uwe, Luetke-Eversloh, Merlin, Golfier, Sven, Von Ahsen, Oliver, Volpin, Valentina, Sorrentino, Antonio, Rathinasamy, Anchana, Xydia, Maria, Lohmayer, Robert, Sax, Julian, Nur-Menevse, Ayse, Hussein, Abir, Stamova, Slava, Beckmann, Georg, Glueck, Julian Marius, Schoenfeld, Dorian, Weiske, Joerg, Zopf, Dieter, Offringa, Rienk, Kreft, Bertolt, Beckhove, Philipp, Willuda, Joerg
Published in Oncoimmunology (01.01.2022)
Published in Oncoimmunology (01.01.2022)
Get full text
Journal Article
Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor
Eder, Iris E, Hoffmann, Jens, Rogatsch, Hermann, Schäfer, Georg, Zopf, Dieter, Bartsch, Georg, Klocker, Helmut
Published in Cancer gene therapy (01.02.2002)
Published in Cancer gene therapy (01.02.2002)
Get full text
Journal Article
Abstract 1666: Regorafenib (BAY 73-4506): preclinical pharmacology and clinical identification and quantification of its major metabolites
Zopf, Dieter, Heinig, Roland, Thierauch, Karl-Heinz, Hirth-Dietrich, Claudia, Hafner, Frank-Thorsten, Christensen, Olaf, Lin, Tiffany, Wilhelm, Scott, Radtke, Martin
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Get full text
Journal Article
Regorafenib (BAY 73‐4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
Wilhelm, Scott M., Dumas, Jacques, Adnane, Lila, Lynch, Mark, Carter, Christopher A., Schütz, Gunnar, Thierauch, Karl‐Heinz, Zopf, Dieter
Published in International journal of cancer (01.07.2011)
Published in International journal of cancer (01.07.2011)
Get full text
Journal Article
Rogaratinib: A potent and selective pan‐FGFR inhibitor with broad antitumor activity in FGFR‐overexpressing preclinical cancer models
Grünewald, Sylvia, Politz, Oliver, Bender, Sebastian, Héroult, Mélanie, Lustig, Klemens, Thuss, Uwe, Kneip, Christoph, Kopitz, Charlotte, Zopf, Dieter, Collin, Marie‐Pierre, Boemer, Ulf, Ince, Stuart, Ellinghaus, Peter, Mumberg, Dominik, Hess‐Stumpp, Holger, Ziegelbauer, Karl
Published in International journal of cancer (01.09.2019)
Published in International journal of cancer (01.09.2019)
Get full text
Journal Article
Abstract 5355: MSLN-targeted thorium-227 conjugate demonstrates increased antitumor activity in combination with bevacizumab and regorafenib
Hagemann, Urs B., Ellingsen, Christine, Kamfenkel, Claudia, Zopf, Dieter, Fonslet, Jesper, Nielsen, Carsten, Hennekes, Hartwig, Cuthbertson, Alan S., Mumberg, Dominik
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Abstract 3935: Differentiation of multi-kinase inhibitors by in vivo transcript profiling: Potential implications for HCC therapy
Ellinger-Ziegelbauer, Heidrun, Fiebig, Lukas, Schladt, Ludwig, Ziegelbauer, Karl, Sommer, Anette, Zopf, Dieter
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
EXTH-64. ESTABLISHING A CLINICALLY RELEVANT MOUSE MODEL OF MESENCHYMAL GLIOBLASTOMA FOR STUDYING TME TARGETING TREATMENTS
Connor, Kate, White, Kieron, Clerkin, James, Shiels, Liam, Sweeney, Kieron, Van Brussel, Thomas, Arijs, Ingrid, Lambrechts, Diether, Shankar, Gautam, de Smet, Frederik, Zopf, Dieter, Maher, Stephen, Marignol, Laure, Dicker, Patrick, Prehn, Jochen, O'Brien, David, Byrne, Annette
Published in Neuro-oncology (Charlottesville, Va.) (10.11.2023)
Published in Neuro-oncology (Charlottesville, Va.) (10.11.2023)
Get full text
Journal Article
A targeted thorium-227 conjugate demonstrates efficacy in preclinical models of acquired drug resistance and combination potential with chemotherapeutics and antiangiogenic therapies
Zitzmann-Kolbe, Sabine, Kristian, Alexander, Zopf, Dieter, Kamfenkel, Claudia, Politz, Oliver, Ellingsen, Christine, Hilbig, Jochen, Juul, Mark U, Fonslet, Jesper, Nielsen, Carsten H, Schatz, Christoph A, Bjerke, Roger M, Cuthbertson, Alan S, Mumberg, Dominik, Hagemann, Urs B
Published in Molecular cancer therapeutics (05.09.2023)
Published in Molecular cancer therapeutics (05.09.2023)
Get full text
Journal Article